Bevacizumab in the treatment of metastatic colorectal cancer: the RFOM in the experience of the A.O. University of Siena
DOI:
https://doi.org/10.33393/grhta.2015.326Downloads
Download data is not yet available.
Downloads
Published
2015-03-17
How to Cite
Paoletti, D., & Giorgi, S. (2015). Bevacizumab in the treatment of metastatic colorectal cancer: the RFOM in the experience of the A.O. University of Siena. Global and Regional Health Technology Assessment, 2(1), 61–62. https://doi.org/10.33393/grhta.2015.326
Issue
Section
Correspondence
License
Copyright (c) 2015 The authors
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.